Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

FTSE recoups early losses as cyclicals recover

Published 20/11/2017, 16:58
Updated 20/11/2017, 16:58
© Reuters. London Stock Exchange interiors are seen during Israel's PM Netanyahu's visit in London

© Reuters. London Stock Exchange interiors are seen during Israel's PM Netanyahu's visit in London

By Kit Rees and Helen Reid

LONDON (Reuters) - Britain's top share index recovered from earlier losses to inch higher at the start of the week as cyclical sectors made a comeback, though the UK market lagged European benchmarks and Shire was a loser among health stocks.

The blue chip FTSE 100 (FTSE) index ended 0.1 percent higher at 7,389.46 points, having hit a new seven-week low, while mid caps (FTMC) gained 0.4 percent.

The UK lagged European markets which made a robust recovery, shrugging off the breakdown of coalition talks in Germany.

Strength in sterling put pressure on the index's dollar-earnings constituents.

"I think for the moment people are still fixated on progress in negotiations between the UK and the EU ... the currency reacts to that most quickly," Stephen Macklow-Smith, head of Europe equity strategy at JPMorgan (NYSE:JPM) Asset Management, said.

"There is scope for sterling to bounce if we get a fairly benign deal, and that would then translate to some rotation within the market, because when sterling weakens, overseas earners do well," Macklow-Smith added.

Though individual stock moves were in general fairly muted, shares in health firm Shire (L:SHP) fell 2.7 percent, the biggest FTSE fallers.

Shire's stock was down in a readacross reaction from some positive drug trial results for Swiss peer Roche (S:ROG), whose shares jumped 6.5 percent.

Shares in AstraZeneca (L:AZN) also edged 0.2 percent lower.

Cyclicals made a recovery after a weak start.

Materials and industrials stocks added the most points to the index, while heavyweight financials HSBC (L:HSBA), Prudential (L:PRU) and Standard Chartered (L:STAN) remained muted, down 0.3 percent to 0.4 percent.

Commodities stocks recovered after early weakness. Oil majors BP (L:BP) and Royal Dutch Shell (L:RDSa) edged up 0.1 to 0.4 percent, while miners Anglo American (L:AAL) and Glencore (L:GLEN) also pulled out of an early dip, gaining 1.4 to 1.5 percent as copper prices edged higher. [O/R] [MET/L]

Health stocks were also strong movers on the mid-cap index (FTMC). Hikma (L:HIK) shares jumped 5.9 percent, while Spire Healthcare (L:SPI) sank 9.5 percent after South African private hospital group Mediclinic (L:MDCM) said it would not make another offer for the company.

Shares in Mediclinic (L:MDCM) fell 2.4 percent on the FTSE 100.

TalkTalk (L:TALK) shares sank 4.5 percent after Citi lowered its price target on the stock, saying the company may need to further cut its dividend in order to stay within debt covenants.

Shares in Thomas Cook (L:TCG), however, climbed 5.2 percent thanks to some supportive broker action.

HSBC started its coverage of Thomas Cook with a "buy" rating, while Panmure Gordon & Co raised the stock to "hold" from "sell".

"Tour operators have been on the winning side of incredibly polarised share price performance across the Travel & Leisure sector this year," analysts at Panmure said in a note. Thomas Cook's shares have risen nearly 35 percent so far this year.

"(Thomas Cook's) shares have performed strongly on increasing confidence that consensus earnings expectations have stabilised, after three years of decline," Panmure analysts added.

© Reuters. London Stock Exchange interiors are seen during Israel's PM Netanyahu's visit in London

Industrial component distributor Diploma (L:DPLM) jumped 10.7 percent, helping mid-caps and blue-chip industrials outperform, after the firm reported a 19 percent rise in full-year profit.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.